Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Patients who should not receive BPC-157 include: those with active or recent malignancies (due to angiogenic concerns), pregnant or breastfeeding women (no reproductive toxicology data in humans), patients on anticoagulation therapy (theoretical bleeding risk from angiogenesis at ulcer sites), and minors (no pediatric data of any kind)
Use a new needle for each dose to reduce the chances of infection and irritating the skin
It contains 0.9% benzyl alcohol which helps the solution remain sterile for an extended period of time
For the CY 2026 OPPS/ASC proposed rule, HCPCS code G0239 had a geometric mean cost of around $43.00, and we proposed to continue to assign the procedure to APC 5732 (Level 2 Minor Procedures), which has a payment rate of around $39.00
We welcome your questions about emerging therapies and are here to support your health with proven, safe, and effective treatments
Compound Profiles and Functional Architecture To support rigorous, repeatable analytical trials, the 20mg blend is manufactured to an exact 1:1 quantitative ratio featuring two highly verified research sequences: BPC-157: A synthetic sequence representing the fully functional fragment of human gastric juice protein, optimized for extreme chemical stability in liquid environments and recognized for its extensive cytoprotective properties across soft tissue models
US$ 21.82
US$ 21.96
US$ 28.61
US$ 27.86
US$ 25.10
US$ 24.33
US$ 26.01
